Protection against post-ischemic behavioral pathology by the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline (NBQX) in the gerbil.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Neuroscience Letters

• Publication date

  1991-12-09

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/0304-3940(91)90591-GPMID 1667818
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The neuroprotective actions of 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) in a rat focal ischaemia model.

  1992cited by this paper
• Cerebral ischemia, locomotor activity and spatial mapping.

  1990cited by this paper
• 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia.

  1990cited by this paper
• Direct Evidence That Excitotoxicity in Cultured Neurons Is Mediated via N‐Methyl‐D‐Aspartate (NMDA) as well as Non‐NMDA Receptors

  1989cited by this paper
• Motor activity changes following cerebral ischemia in gerbils are correlated with the degree of neuronal degeneration in hippocampus.

  1988cited by this paper
• Human amnesia and the medial temporal region: enduring memory impairment following a bilateral lesion limited to field CA1 of the hippocampus

  1986cited by this paper
• Mechanisms of memory.

  1986cited by this paper
• Elevation of the Extracellular Concentrations of Glutamate and Aspartate in Rat Hippocampus During Transient Cerebral Ischemia Monitored by Intracerebral Microdialysis

  1984cited by this paper
• The effects of bilateral hippocampal lesions in rats.

  1963cited by this paper
• Alternation and exploration in rats with hippocampal lesions.

  1962cited by this paper
• LOSS OF RECENT MEMORY AFTER BILATERAL HIPPOCAMPAL LESIONS

  1957cited by this paper

• Kainate Receptor Antagonists: Recent Advances and Therapeutic Perspective

  2023cites this paper
• Design and synthesis of novel 7-heterocycle-6-trifluoromethyl-3-oxoquinoxaline-2-carboxylic acids bearing a substituted phenyl group as superior AMPA receptor antagonists with good physicochemical properties.

  2006cites this paper
• Design, synthesis, and AMPA receptor antagonistic activity of a novel 6-nitro-3-oxoquinoxaline-2-carboxylic acid with a substituted phenyl group at the 7 position.

  2005cites this paper
• Ischemia-related changes in galanin expression in the dentate hilar region after transient forebrain ischemia in gerbils.

  2005cites this paper
• Expression and changes of galanin in neurons and microglia in the hippocampus after transient forebrain ischemia in gerbils.

  2004cites this paper
• Comparison of the AMPA Antagonist Action of New 2,3-Benzodiazepines in Vitro and Their Neuroprotective Effects in Vivo

  2004cites this paper
• Synthesis and AMPA receptor antagonistic activity of a novel 7-imidazolyl-6-trifluoromethyl quinoxalinecarboxylic acid with a substituted phenyl group and improved its good physicochemical properties by introduced CF3 group.

  2004cites this paper
• Synthesis and AMPA receptor antagonistic activity of a novel class of quinoxalinecarboxylic acid with a substituted phenyl group at the C-7 position.

  2003cites this paper
• Functional Characterization of YM928, a Novel Noncompetitive AMPA Receptor Antagonist

  2003cites this paper
• Functional Characterization of YM928, a Novel Noncompetitive α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Antagonist

  2003cites this paper
• Pharmacological evidence for a correlation between hippocampal CA1 cell damage and hyperlocomotion following global cerebral ischemia in gerbils.

  2003cites this paper
• The pharmacological manipulation of glutamate receptors and neuroprotection.

  2002cites this paper
• The Effects of Pharmacotherapy and Training on Functional Recovery after Global and Focal Cerebral Ischemia in Rats

  2001cites this paper
• Protection by Pyruvate against Transient Forebrain Ischemia in Rats

  2001cites this paper
• Disruption of the GluR2-NSF interaction protects primary hippocampal neurons from ischemic stress.

  2001cites this paper
• LY377770, a novel iGlu5 kainate receptor antagonist with neuroprotective effects in global and focal cerebral ischaemia.

  2000cites this paper
• Glial glutamate transporter GLT-1 down-regulation precedes delayed neuronal death in gerbil hippocampus following transient global cerebral ischemia.

  2000cites this paper
• Rodent Models of Global Cerebral Ischemia

  2000cites this paper
• Global ischemia and behavioural deficits.

  1999cites this paper
• The neuroprotective and hypothermic effect of GYKI-52466, a non-competitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-antagonist on histological and behavioural variables in the gerbil global ischemia model.

  1999cites this paper
• Dizocilpine maleate, MK-801, but not 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline, NBQX, prevents transneuronal degeneration of nigral neurons after neurotoxic striatal-pallidal lesion.

  1999cites this paper
• The problem of assessing effective neuroprotection in experimental cerebral ischemia.

  1998cites this paper
• Decahydroisoquinolines: novel competitive AMPA/kainate antagonists with neuroprotective effects in global cerebral ischaemia.

  1998cites this paper
• Clomethiazole (Zendra) in acute ischemic stroke: basic pharmacology and biochemistry and clinical efficacy.

  1998cites this paper
• Longitudinal distribution of components of excitatory synaptic input to motoneurones during swimming in young Xenopus tadpoles: experiments with antagonists

  1998cites this paper
• To what extent have functional studies of ischaemia in animals been useful in the assessment of potential neuroprotective agents?

  1998cites this paper
• Neuropharmacology of AMPA and kainate receptors.

  1998cites this paper
• Clomethiazole (Zendra®) in Acute Ischemic Stroke: Basic Pharmacology and Biochemistry and Clinical Efficacy

  1998cites this paper
• Pharmacology of AMPA antagonists and their role in neuroprotection.

  1997cites this paper
• Domoic Acid Neurotoxicity in Cultured Cerebellar Granule Neurons Is Mediated Predominantly by NMDA Receptors that Are Activated as a Consequence of Excitatory Amino Acid Release

  1997cites this paper
• Neuroprotective Properties of the Benzodiazepine Receptor, Partial Agonist PNU-101017 in the Gerbil Forebrain Ischemia Model

  1997cites this paper
• Studies on the influence of enriched-environment housing combined with systemic administration of an alpha2-adrenergic antagonist on spatial learning and hyperactivity after global ischemia in rats.

  1997cites this paper
• Development and characterization of a model of glutamate and domoate toxicity in cultured rat cerebellar granule neurons

  1997influential citation
• Effects of Ca2+ and Na+ channel inhibitors in vitro and in global cerebral ischaemia in vivo.

  1997cites this paper
• Stereoselective effects-of 2,3-benzodiazepines in vivo: electrophysiology and neuroprotection studies.

  1996cites this paper
• Novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonists: synthesis and structure-activity relationships of 6-(1H-imidazol-1-yl)-7-nitro-2,3(1H,4H)-pyrido[2,3-b]pyrazinedione and related compounds.

  1996cites this paper
• Effects of Glutamate Agonists and Antagonists on Ischemic Damage of Hippocampal Neurons

  1996cites this paper
• Cellular expression of ionotropic glutamate receptor subunits on specific striatal neuron types and its implication for striatal vulnerability in glutamate receptor-mediated excitotoxicity.

  1996cites this paper
• Current Concepts of Excitotoxicity

  1996cites this paper
• Therapeutic Potential of AMPA Receptor Ligands in Neurological Disorders

  1996cites this paper
• Post-ischemic therapy with CGS-19755 (alone or in combination with hypothermia) in gerbils.

  1995cites this paper
• AMPA antagonist LY293558 does not affect the severity of hypoxic-ischemic injury in newborn pigs.

  1995cites this paper
• The sigma receptor ligand JO 1784 (igmesine hydrochloride) is neuroprotective in the gerbil model of global cerebral ischaemia.

  1995cites this paper
• Kainate receptors are involved in the glutamate-induced indirect, purinergic inhibition of [3H]-noradrenaline release in rabbit brain cortex

  1995cites this paper
• Reduced Mortality and Brain Damage After Locomotor Activity in Gerbil Forebrain Ischemia

  1994cites this paper
• Effects of MK-801 and NBQX on Acute Recovery of Piglet Cerebral Metabolism after Hypothermic Circulatory Arrest

  1994cites this paper
• Comparative patch clamp studies on the kinetics and selectivity of glutamate receptor antagonism by 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) and 1-(4-amino-phenyl)-4-methyl-7,8-methyl-endioxyl-5H-2,3-benzodiaze pine (GYKI 52466).

  1994cites this paper
• 6-(1H-imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione hydrochloride (YM90K) and related compounds: structure-activity relationships for the AMPA-type non-NMDA receptor.

  1994cites this paper
• Role of Metabotropic Glutamate Receptors in Neuronal Degeneration

  1994cites this paper
• The pharmacology of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate antagonists and their role in cerebral ischaemia.

  1994cites this paper
• The nerve of glaucoma!

  1994cites this paper
• 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline protects against both AMPA and kainate-induced lesions in rat striatum in vivo.

  1994cites this paper
• Intravenous NBQX inhibits spontaneously occurring sympathetic nerve activity and reduces blood pressure in cats.

  1994cites this paper
• The neuroprotective actions of chlormethiazole.

  1994cites this paper
• A short synthesis of GYKI 52466

  1993cites this paper
• NBQX is a selective non-NMDA receptor antagonist in rat hippocampal slice.

  1993cites this paper
• NBQX inhibits AMPA-induced locomotion after injection into the nucleus accumbens.

  1993cites this paper
• Prevention of mortality induced by perinatal asphyxia: Hypothermia or glutamate antagonism?

  1993cites this paper
• Neuroexcitation, excitotoxicity and human neurological disease.

  1993cites this paper
• Contributory mechanisms in the causation of neurodegenerative disorders.

  1993cites this paper
• Excitatory Amino Acids Contribute to the Pathogenesis of Perinatal Hypoxic‐Ischemic Brain Injury

  1992cites this paper
• Biochemical changes and secondary injury from stroke and trauma

  1992cites this paper